Archimedes Tech SPAC Partners III Co. filed its Form 10-Q for the quarterly period ended June 30, 2026 with the U.S. Securities and Exchange Commission, reporting financial results following the completion of its Initial Public Offering earlier in the year.
Key Highlights
- Trust Account: A demand deposit held in the Trust Account totaled $280,254,125 as of June 30, 2026, according to the filing.
- Net Income: The company reported net income of $2,288,115 for the three months ended June 30, 2026, and $3,862,169 for the six months ended June 30, 2026.
- Redeemable Shares: 27,600,000 ordinary shares are subject to possible redemption at a value of $10.15 per share as of June 30, 2026.
- Shareholders' Deficit: Total shareholders' deficit stood at $(8,538,684) as of June 30, 2026, compared to $(44,521) at December 31, 2025.
- Shares Outstanding: As of August 12, 2026, there were 35,262,000 ordinary shares issued and outstanding.
- Over-Allotment Exercised: The underwriters exercised their over-allotment option in full on January 26, 2026, as part of the closing of the Initial Public Offering, according to the filing.
Archimedes Tech SPAC Partners III Reports Q2 2026 Results After IPO Closing
Archimedes Tech SPAC Partners III Co., listed on the Nasdaq Stock Market LLC under trading symbols NASDAQ:ARCI (ordinary shares), ARCIU (units), and ARCIW (warrants), filed its quarterly report covering the period ended June 30, 2026. The filing reflects the company's first full reporting period following the closing of its Initial Public Offering, which occurred in January 2026. Total assets reached $281,499,401 as of June 30, 2026, up from $182,090 at December 31, 2025, driven primarily by the demand deposit held in the Trust Account of $280,254,125.
The company reported general and administrative expenses of $200,057 for the three months ended June 30, 2026, and $410,310 for the six months ended June 30, 2026. Other income, consisting of interest earned on the Trust Account and bank account, totaled $2,488,172 for the quarter and $4,272,479 for the six-month period. Basic and diluted net income per share was $0.06 for both redeemable and non-redeemable ordinary shares for the three months ended June 30, 2026. Net cash used in operating activities for the six months ended June 30, 2026 was $(591,964), according to the filing.
On January 22, 2026, the company issued an additional 1,150,000 Founder Shares to the Sponsor through a share capitalization, resulting in the Sponsor holding an aggregate of 6,900,000 Founder Shares, the filing disclosed. Of those, 900,000 shares had been subject to forfeiture if the over-allotment option was not exercised in full; the underwriters exercised that option in full on January 26, 2026, and accordingly those shares are no longer subject to forfeiture. The company also sold 762,000 private placement units for total proceeds of $7,620,000. A deferred underwriting fee of $9,660,000 is recorded as a long-term liability.
What Was Disclosed
Archimedes Tech SPAC Partners III disclosed its balance sheet, income statement, and cash flows for the period ended June 30, 2026, reflecting IPO proceeds held in trust, a shareholders' deficit of $(8,538,684), and net income of $3,862,169 for the six-month period.




Please wait processing your request...